To prioritize funding for the National Institutes of Health to discover treatments and cures, to maintain global leadership in medical innovation, and to restore the purchasing power the NIH had after the historic doubling campaign that ended in fiscal year 2003.
The bill’s titles are written by its sponsor.
Sponsor. Representative for Connecticut's 3rd congressional district. Democrat.
Last Updated: Jan 26, 2015
Length: 7 pages
Jan 26, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on January 26, 2015, in a previous session of Congress, but was not enacted.
Sep 18, 2014
Earlier Version — Introduced
This activity took place on a related bill, H.R. 5580 (113th).
Jan 26, 2015
H.R. 531 (114th) was a bill in the United States Congress.
How to cite this information.
Civic Impulse. (2017). H.R. 531 — 114th Congress: Accelerating Biomedical Research Act. Retrieved from https://www.govtrack.us/congress/bills/114/hr531
“H.R. 531 — 114th Congress: Accelerating Biomedical Research Act.” www.GovTrack.us. 2015. November 20, 2017 <https://www.govtrack.us/congress/bills/114/hr531>
|title=H.R. 531 (114th)
|accessdate=November 20, 2017
|author=114th Congress (2015)
|date=January 26, 2015
|quote=Accelerating Biomedical Research Act